Sponsors and Exhibitors | Foundation for Women & Girls with Blood Disorders

Thank you to our sponsors for their generous support.
Their partnership helps make FWGBD 2026 possible.

Satellite Symposia

Saturday, October 10th, 2026, at 7:00 AM

ITP Clinical Case Review & Real-World Experiences

Saturday, October 10th, 2026, at 6:30 PM

A Clinical Approach to HFXD and PLGD-1: Recognition, Testing, and Treatment

Sunday, October 11th, 2026, at 7:30 AM

A Treatment Option for Your Patients with Warm Autoimmune Hemolytic Anemia

Champion Level Sponsor

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.

Gold Level Sponsors

Our Hemophilia A Community Commitment: Here for Generations. Here for Life. In strong partnership with the hemophilia A community, Genentech is advancing scientific innovation, enabling patient access, and advocating for a future to change what’s possible for patients.

Takeda is focused on creating better health and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core areas including gastroenterology, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.

Octapharma is one of the largest human protein manufacturers globally, developing and producing human proteins from human plasma and cell lines. Octapharma supports the treatment of patients in three therapeutic areas: Immunotherapy, Hematology, and Critical Care.

Silver Level Sponsors

At Johnson & Johnson, we believe health is everything. We are building a world where complex diseases are prevented, treated, and cured.

Sanofi’s global specialty care business unit focuses on rare diseases, rare blood disorders, neurology, immunology, and oncology leveraging science and innovation to help improve people’s lives.

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease.

As a regional comprehensive hemophilia treatment center, we diagnose and treat children, teens and young adults with all types of bleeding or clotting disorders.